DCN and breast cancer: Collectively, these data highlight that decorin functions as a central regulator of the BC microenvironment: its loss promotes fibroblast activation and tumour invasion, while its expression suppresses angiogenesis and lymphangiogenesis, consolidating decorin as both a biomarker of stromal homeostasis and a promising therapeutic target.